Cullinan Therapeutics, Inc.
CGEM
$9.07
$0.111.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 303.83M | 398.98M | 578.08M | 662.50M | 433.01M |
| Total Receivables | -- | 6.46M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.95M | 9.23M | 13.96M | 15.30M | 12.71M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 317.77M | 414.67M | 592.04M | 677.80M | 445.72M |
|
|
|||||
| Total Current Assets | 317.77M | 414.67M | 592.04M | 677.80M | 445.72M |
| Net Property, Plant & Equipment | 2.16M | 2.35M | 2.78M | 2.96M | 3.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 366.00K | 366.00K | 460.00K | 460.00K | 460.00K |
| Total Assets | 579.68M | 621.82M | 653.25M | 681.22M | 449.43M |
|
|
|||||
| Total Accounts Payable | 3.40M | 1.68M | 2.12M | 1.56M | 3.71M |
| Total Accrued Expenses | 19.81M | 26.23M | 19.12M | 18.49M | 15.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.35M | 1.30M | 1.26M | 1.22M | 1.33M |
| Total Finance Division Other Current Liabilities | 2.80M | 1.44M | 1.71M | 2.22M | 1.52M |
| Total Other Current Liabilities | 2.80M | 1.44M | 1.71M | 2.22M | 1.52M |
| Total Current Liabilities | 27.35M | 30.65M | 24.20M | 23.48M | 21.93M |
|
|
|||||
| Total Current Liabilities | 27.35M | 30.65M | 24.20M | 23.48M | 21.93M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 493.00K | 849.00K | 1.19M | 1.52M | 1.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.84M | 31.50M | 25.39M | 25.00M | 23.77M |
|
|
|||||
| Common Stock & APIC | 968.08M | 958.70M | 947.49M | 936.73M | 664.00M |
| Retained Earnings | -416.74M | -368.24M | -320.59M | -280.03M | -238.01M |
| Treasury Stock & Other | 505.00K | -133.00K | 970.00K | -476.00K | -331.00K |
| Total Common Equity | 551.84M | 590.33M | 627.86M | 656.22M | 425.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 551.84M | 590.33M | 627.86M | 656.22M | 425.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 551.84M | 590.33M | 627.86M | 656.22M | 425.67M |
|
|
|||||